Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q3 FY26 results · Oct–Dec 2025
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,261.90 crore (up 1.1% from Q3 FY25) and net profit of ₹301.46 crore (up 12.2% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a standalone basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,261.90 | 1,247.63 | +1.1% | 1,150.17 | +9.7% |
| Other income | 12.41 | 9.71 | +27.8% | 9.90 | +25.4% |
| Total income | 1,274.31 | 1,257.34 | +1.3% | 1,160.07 | +9.8% |
| Profit before tax | 402.04 | 364.13 | +10.4% | 281.78 | +42.7% |
| Net profit for the period | 301.46 | 268.59 | +12.2% | 209.86 | +43.6% |
| EPS, basic (₹) | 92.87 | 82.74 | +12.2% | 64.65 | +43.7% |
| Net margin (%) | 23.9 | 21.5 | 18.2 |
Standalone
- Filed with BSE
- 30 Jan 2026, 22:56 IST
- Board meeting
- 30 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE